Huons Global
Humedix
HuM&C
Huons BioPharma
Huons Meditech
Huonslab
Food Assemble
Huons USA
Huons Japan
HuonsLifeSciences
Huons N
PanGen Biotech
Bio Rosette
Huons
CEO Greetings
Vision & Mission
HUONS History
CI
Location
HUONS in the World
Products
Injectable Product
Eye Drop
Oral Solid Form
Contact Us
Global R&D
R&D Headquarter
R&D Achievement
World Class 300
Press Release
NEWS
PR Video
Investors
Investor Relations
Disclosure Information
Financial Information
IR NEWS
Recruitment
A wholesale web order
Language
KOR
ENG
Investors
A company respecting the human life
Investors
Huons
Products
Global R&D
Press Release
Investors
Recruitment
Disclosure Information
Investor Relations
Disclosure Information
Financial Information
IR NEWS
Disclosure Information
Full disclosure information
DATE
SUBJECT
SUBMITTER
2026/03/17
Material Management Information related to Judgment of Investment(IND Approval Determination)(IND Approval for HUC1-394 (NCP112) Eye Drops Phase 2 Clinical Trial)
2026/03/16
Resolutions for Convocation of General Meeting of Shareholders
2026/03/13
[Revised]Decision on Debt Guarantee for Others
2026/03/05
Decision on Debt Guarantee for Others
2026/02/19
30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)
2026/02/19
Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)
2026/02/19
Timely Disclosure Related(Fair Disclosure)
2026/02/19
Forecast on Business Performance according to Consolidated Financial Statements(Fair Disclosure)
2026/02/19
Decision on Cash Dividend and Dividend in Kind
2026/02/19
Notice on Status of Implementation of Self-Regulatory Program of the Fair Trade